(Q51312748)

3 April 2018

reason for preferred rank

title

Clinical Response to Amitriptyline and Chlordiazepoxide-Amitriptyline (Limbitrol®) in Anxiety-Depressive States: A Double-Blind Study (English)

1 reference

https://api.crossref.org/works/10.1016/S0033-3182(73)71352-9

11 February 2023

Clinical response to amitriptyline and chlordiazepoxide-amitriptyline (Limbitrol) in anxiety-depressive states. A double-blind study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4604233

11 February 2023

1 reference

M. Smith

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4604233

11 February 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=4604233

11 February 2023

publication date

1 May 1973

1 reference

3 April 2018

full work available at URL

https://api.elsevier.com/content/article/PII:S0033318273713529?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0033-3182(73)71352-9

https://api.elsevier.com/content/article/PII:S0033318273713529?httpAccept=text/plain

11 February 2023

1 reference

https://api.crossref.org/works/10.1016/S0033-3182(73)71352-9

11 February 2023

1 reference

3 April 2018

volume

14

1 reference

3 April 2018

issue

3

1 reference

3 April 2018

page(s)

168-175

1 reference

3 April 2018

AMITRIPTYLINE IN DEPRESSIVE STATES: SIX-MONTH TREATMENT RESULTS.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2873%2971352-9

7 January 2021

Problems of differential diagnosis and choice of therapy in depressive states

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2873%2971352-9

7 January 2021

Treatment of Anxiety States by Antidepressant Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2873%2971352-9

7 January 2021

EARLY EFFECTS OF CHLORDIAZEPOXIDE (LIBRIUM) USED WITH PSYCHOTHERAPY

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2873%2971352-9

7 January 2021

New psychotherapeutic agent, chlordiazepoxide. Use in treatment of anxiety states and related symptoms.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2873%2971352-9

7 January 2021

CHLORDIAZEPOXIDE (LIBRIUM) A CLINICAL TRIAL OF ITS USE IN CONTROLLING SYMPTOMS OF ANXIETY.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2873%2971352-9

7 January 2021

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2873%2971352-9

7 January 2021

Drug treatment in depression. Antidepressant or tranquilizer?

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2873%2971352-9

7 January 2021

Self-rating depression scale in an outpatient clinic. Further validation of the SDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2873%2971352-9

7 January 2021

Reflections on the Specificity of Action of Anti-Depressants

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2873%2971352-9

7 January 2021

THE CONTROLLED EVALUATION OF IMIPRAMINE AND AMITRIPTYLINE IN HOSPITALIZED DEPRESSED PSYCHIATRIC PATIENTS. A CONTRIBUTION TO THE METHODOLOGY OF DRUG EVALUATION

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2873%2971352-9

7 January 2021

Drug therapy of depression. Amitriptyline, perphenazine, and their combination in different syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2873%2971352-9

7 January 2021

The pharmacology of antidepressant agents

series ordinal

2

1 reference

https://api.crossref.org/works/10.1016/S0033-3182(73)71352-9

Amitriptyline in depressive states

11 February 2023

series ordinal

3

1 reference

https://api.crossref.org/works/10.1016/S0033-3182(73)71352-9

11 February 2023

Identifiers

1 reference

3 April 2018

1 reference

3 April 2018